MONDAY, Nov. 7, 2022 (HealthDay News) — The antiviral pill Paxlovid not only reduces hospitalization and death after catching COVID-19: New research shows it also cuts the chances of long COVID by roughly 25%. The drug, which combines a newer antiviral called nirmatrelvir with an older medication known as ritonavir,Continue Reading
MONDAY, Nov. 7, 2022 (HealthDay News) — As health experts warn about RSV infections in infants and toddlers, adults should know that they, too, can become severely ill from the virus. Respiratory syncytial virus (RSV) is not always the mild respiratory illness people think it is but can lead toContinue Reading
FRIDAY, Nov. 4, 2022 (HealthDay News) — The world desperately needs new antibiotics to fight infection as bacteria become resistant to existing options. GSK has developed a new antibiotic to treat urinary tract infections (UTIs) that appears to be so effective the pharmaceutical company stopped testing early on the recommendationContinue Reading
FRIDAY, Nov. 4, 2022 (HealthDay News) — While it isn’t possible to tell parents how long their child will need to remain in intensive care with a serious case of RSV, new research has unearthed clues that may make it easier to predict which kids will require a longer stay.Continue Reading
THURSDAY, Nov. 3, 2022 (HealthDay News) — Monkeypox spreads even before a person shows any telltale lesions or other symptoms, a new study suggests. More than half of monkeypox transmission in the United Kingdom occurred in the pre-symptomatic phase, the researchers said. The new findings — published online Nov. 2Continue Reading
THURSDAY, Nov. 3, 2022 (HealthDay News) — Out of the more than 25,000 U.S. cases of monkeypox reviewed in a new study, just 0.3% occurred in people under the age of 18, new government data shows. Most of the kids and teens who contracted the virus — 89% — “wereContinue Reading
TUESDAY, Nov. 1, 2022 (HealthDay News) — A new malaria antibody treatment may keep more people free of the sometimes deadly disease for up to six months in regions where infection rates are high. Instead of requiring the immune system to make enough antibodies, this experimental drug provides those whoContinue Reading
MONDAY, Oct. 31, 2022 (HealthDay News) — Nearly everyone has heard of Paxlovid rebound, where COVID-19 symptoms return after taking the antiviral and then feeling better. It even happened to President Joe Biden. But new research shows it also happens to patients who don’t take the medication. “Our study suggestsContinue Reading
MONDAY, Oct. 31, 2022 (HealthDay News) – It could be harder to fill a prescription for the widely used antibiotic amoxicillin because of a shortage that appears to be linked to an ongoing surge in RSV infections across the United States. Supplies of amoxicillin oral solution, which is typically usedContinue Reading
FRIDAY, Oct. 28, 2022 (HealthDay News) — While a potential COVID winter surge and the impending flu season get a lot of attention, doctors are worried about another virus. This one is RSV — short for respiratory syncytial virus — and hospitals across the country are seeing a surge ofContinue Reading